Enforcement Report - Week of April 13, 2022
Apotex Inc's Generic Calcium Carbonate;Risedronate Sodium Receives Tentative Approval in US
Macleod's Generic RisedronateI Sodium Receives Approval In US
Aurobindo's Generic Risedronate Sodium Received Approval In US
Top-line data from a late-stage trial of Amgen's Prolia in osteoporosis patients receiving glucocorticoid therapy show that all primary and secondary targets being investigated were met.
Orchid Hlthcare`s Generic Risedronate Sodium tentatively approved in US to treat osteoporosis
Macleods Pharma`s Generic Risedronate Sodium approved in US for Osteoporosis
U.S. state Medicaid programs spent $1.3 billion before rebates in 2014 on Gilead Sciences' new hepatitis C drugs to treat fewer than 2.4 percent of enrollees with the liver disease, according to a U.S. Senate investigation into pricing of the blockbuster medicines.
Teva Pharma Announces U.S. Launch of Generic Actonel Tabs
Amneal Signs Deal to Acquire the Generic Business of Actavis Australia